Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Active, not recruiting · NCT01038778 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, clear cell renal carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-13 | NCT01038778 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University/Sidney Kimmel Cancer Center | Baltimore | United States | 238 |
| Ohio State University Comprehensive Cancer Center | Columbus | United States | 548 |
| Roswell Park Cancer Institute | Buffalo | United States | 382 |
| USC / Norris Comprehensive Cancer Center | Los Angeles | United States | 249 |